RAPT - CIK 0001673772
RAPT Therapeutics, Inc. (RAPT) reported revenue of $0.00 for fiscal year 2023, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2023 | $0.00 | -100.0% |
| FY 2022 | $1.53M | -60.0% |
| FY 2021 | $3.81M | -24.4% |
| FY 2020 | $5.04M | - |
RAPT Therapeutics, Inc. (RAPT) reported revenue of $0.00 for fiscal year 2023, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.